Regression of cardiac angiosarcoma in a 17-year-old: a percutaneous biopsy effect.

IF 3.2 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Cardio-oncology Pub Date : 2024-07-23 DOI:10.1186/s40959-024-00239-9

Noor Sharrack, Martine Parent, Christopher Lethaby, Ulrich Rosendahl, Alexander R Lyon, Maryum Farooq, Haqeel Jamil, John P Greenwood, Sven Plein, Ananth Kidambi

{"title":"Regression of cardiac angiosarcoma in a 17-year-old: a percutaneous biopsy effect.","authors":"Noor Sharrack, Martine Parent, Christopher Lethaby, Ulrich Rosendahl, Alexander R Lyon, Maryum Farooq, Haqeel Jamil, John P Greenwood, Sven Plein, Ananth Kidambi","doi":"10.1186/s40959-024-00239-9","DOIUrl":null,"url":null,"abstract":"Background: Cardiac angiosarcoma is a very rare and aggressive primary cardiac tumor associated with poor prognosis. Diagnosis is often delayed due to non-specific symptoms, with most cases involving metastases at the time of diagnosis. We describe a unique case of apparent tumor regression of cardiac angiosarcoma post percutaneous biopsy.Case presentation: A young male was admitted with suspected pericarditis. Echocardiogram revealed a pericardial mass. Cardiovascular magnetic resonance (CMR) suggested primary cardiac malignancy. Percutaneous biopsy was inconclusive, with subsequent CMR demonstrating apparent tumor regression. Interval imaging revealed further tumor growth, and surgical biopsy revealed primary cardiac angiosarcoma (PCAS). Causes of tumor regression following percutaneous biopsy are discussed.Conclusions: Cases of suspected primary cardiac malignancy require careful follow up with serial multimodality imaging. Percutaneous biopsy effects should be considered in cases of tumor regression, and serial imaging should be planned afterwards.","PeriodicalId":9804,"journal":{"name":"Cardio-oncology","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11264432/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardio-oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40959-024-00239-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Cardiac angiosarcoma is a very rare and aggressive primary cardiac tumor associated with poor prognosis. Diagnosis is often delayed due to non-specific symptoms, with most cases involving metastases at the time of diagnosis. We describe a unique case of apparent tumor regression of cardiac angiosarcoma post percutaneous biopsy.

Case presentation: A young male was admitted with suspected pericarditis. Echocardiogram revealed a pericardial mass. Cardiovascular magnetic resonance (CMR) suggested primary cardiac malignancy. Percutaneous biopsy was inconclusive, with subsequent CMR demonstrating apparent tumor regression. Interval imaging revealed further tumor growth, and surgical biopsy revealed primary cardiac angiosarcoma (PCAS). Causes of tumor regression following percutaneous biopsy are discussed.

Conclusions: Cases of suspected primary cardiac malignancy require careful follow up with serial multimodality imaging. Percutaneous biopsy effects should be considered in cases of tumor regression, and serial imaging should be planned afterwards.

查看原文本刊更多论文

一名 17 岁少年心脏血管肉瘤的消退：经皮活检的效果。

背景：心脏血管肉瘤是一种非常罕见的侵袭性原发性心脏肿瘤，预后较差。由于无特异性症状，诊断往往被延误，大多数病例在诊断时已出现转移。我们描述了一例独特的心脏血管肉瘤经皮活检后肿瘤明显消退的病例：一名年轻男性因疑似心包炎入院。超声心动图显示心包肿块。心血管磁共振（CMR）提示原发性心脏恶性肿瘤。经皮活检未得出结论，随后的 CMR 显示肿瘤明显消退。间期成像显示肿瘤进一步生长，手术活检显示为原发性心脏血管肉瘤（PCAS）。本文讨论了经皮活检后肿瘤消退的原因：结论：疑似原发性心脏恶性肿瘤的病例需要通过连续的多模态成像进行仔细随访。在肿瘤消退的病例中应考虑经皮活检的效果，之后应计划进行连续成像。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cardio-oncology Medicine-Cardiology and Cardiovascular Medicine

CiteScore

5.00

自引率

3.00%

发文量

审稿时长

7 weeks